Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development

International Journal of Radiation Biology

Volumn 93, Issue 5, 2017, Pages 507-516

  Bouchard, Gina ^a   Therriault, Hélène ^a   Bujold, Rachel ^b   Saucier, Caroline ^a   Paquette, Benoit ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

circulating tumor cells; cytokine; interleukin 1b; metastasis; radiation; Triple negative breast cancer

Indexed keywords

CD31 ANTIGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 2; AUTACOID; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL PROLIFERATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; EXPERIMENTAL LUNG METASTASIS; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; INFLAMMATION; LIMIT OF QUANTITATION; MAMMARY GLAND; MEDIATOR RELEASE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION CARCINOGENESIS; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; IMMUNOLOGY; LUNG TUMOR; MAMMARY NEOPLASMS, ANIMAL; METASTASIS; RADIOTHERAPY DOSAGE; SECONDARY; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RADIOTHERAPY DOSAGE; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 85009736700     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553002.2017.1270471     Document Type: Article

References (62)

1. Apte RN, Voronov E., 2002. Interleukin-1–a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol. 12:277–290.
2. Apte RN, Voronov E., 2008. Is interleukin-1 a good or bad “guy” in tumor immunobiology and immunotherapy? Immunol Rev. 222:222–241.
3. Badiga AV, Chetty C, Kesanakurti D, Are D, Gujrati M, Klopfenstein JD, Dinh DH, Rao JS., 2011. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One. 6:e20614.
4. Balin-Gauthier D, Delord JP, Rochaix P, Mallard V, Thomas F, Hennebelle I, Bugat R, Canal P, Allal C., 2006. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR. Cancer Chemother Pharmacol. 57:709–718.
5. Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, et al. 2008. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol. 19:142–149.
6. Bohlin K, Cotgreave IA., 1999. Pro-inflammatory cytokines increase the permeability of paracetamol across a human endothelial-smooth muscle cell bilayer model. Scand J Clin Lab Invest. 59:259–266.
7. Bouchard G, Bouvette G, Therriault H, Bujold R, Saucier C, Paquette B., 2013. Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases. Br J Cancer. 109:1829–1838.
8. Bouchard G, Therriault H, Geha S, Berube-Lauziere Y, Bujold R, Saucier C, Paquette B., 2016. Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model. BMC Cancer. 16:361.
9. Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW., 2011. Inflammation and behavioral symptoms after breast cancer treatment:do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 29:3517–3522.
10. Brown JM, Marsa GW., 1978. Effect of dose fractionation on the enhancement by radiation or cyclophosphamide of artificial pulmonary metastases. Br J Cancer. 37:1020–1025.
11. Cao N, Li S, Wang Z, Ahmed KM, Degnan ME, Fan M, Dynlacht JR, Li JJ., 2009. NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance. Radiat Res. 171:9–21.
12. Charaghvandi RK, den Hartogh MD, van Ommen A-MLN, de Vries WJH, Scholten V, Moerland MA, Philippens MEP, Schokker RI, van Vulpen M, van Asselen B, et al. 2015. MRI-guided single fraction ablative radiotherapy for early-stage breast cancer:a brachytherapy versus volumetric modulated arc therapy dosimetry study. Radiother Oncol. 117:477–482.
13. Chen WC, Lai YH, Chen HY, Guo HR, Su IJ, Chen HHW., 2013a. Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor. Histopathology. 63:225–233.
14. Chen X, YU X, Chen J, Yang Z, Shao Z, Zhang Z, Guo X, Feng Y., 2013b. Radiotherapy can improve the disease-free survival rate in triple negative breast cancer patients with T1–T2 disease and one to three positive lymph nodes after mastectomy. The Oncologist 18:141–147.
15. Chou CH, Teng C-M, Tzen K-Y, Chang Y-C, Chen J-H, Cheng JC-H., 2012. MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis. Oncogene. 31:458–468.
16. Dethlefsen C, Hojfeldt G, Hojman P., 2013. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat. 138:657–664.
17. Du J-W, Xu K-Y, Fang L-Y, Qi X-L., 2012. Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer. Mol Med Rep. 6:1099–1102.
18. Duru N, Candas D, Jiang G, Li JJ., 2014. Breast cancer adaptive resistance:HER2 and cancer stem cell repopulation in a heterogeneous tumor society. J Cancer Res Clin Oncol. 140:1–14.
19. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) 2005. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:an overview of the randomised trials. Lancet. 366:2087–2106.
20. Egeblad M, Werb Z., 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2:161–174.
21. Gocheva V, Wang H-W, Gadea BB, Shree T, Hunter KE, Garfall AL, Berman T, Joyce JA., 2010. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24:241–255.
22. Goldberg JE, Schwertfeger KL., 2010. Proinflammatory cytokines in breast cancer:mechanisms of action and potential targets for therapeutics. Curr Drug Targets. 11:1133–1146.
23. Goldstein R, Hanley C, Morris J, Cahill D, Chandra A, Harper P, Chowdhury S, Maher J, Burbridge S., 2011. Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancer. Cancers (Basel). 3:4281–4293.
24. Isoir M, Roque T, Squiban C, Milliat F, Mondon P, Mas-Chamberlin C, Benderitter M, Guipaud O, Tamarat R., 2013. Protective effect of geranylgeranylacetone against radiation-induced delayed effects on human keratinocytes. Radiat Res. 179:232–242.
25. Kollmar O, Scheuer C, Menger MD, Schilling MK., 2006. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis. Ann Surg Oncol. 13:263–275.
26. Lemay R, Archambault M, Tremblay L, Bujold R, Lepage M, Paquette B., 2011. Irradiation of normal mouse tissue increases the invasiveness of mammary cancer cells. Int J Radiat Biol. 87:472–482.
27. Lewis AM, Varghese S, Xu H, Alexander HR., 2006. Interleukin-1 and cancer progression:the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 4:48.
28. Liu Q, Li G, Li R, Shen J, He Q, Deng L, Zhang C, Zhang J., 2010. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol. 100:165–176.
29. Mahamodhossen YA, Liu W, Rong-Rong Z., 2013. Triple-negative breast cancer:new perspectives for novel therapies. Med Oncol. 30:653.
30. Martin O, Anderson RL, Russell P, Cox RA, Ivashkevich A, Swierczak A, Doherty JP, Jacobs DHM, Smith J, Siva S, et al. 2014. Mobilization of viable tumor cells into the circulation during radiation therapy. Int J Radiat Oncol Biol Phys. 88:395–403.
31. Mcbride H., 1995. Cytokine cascades in late normal tissue radiation responses. Int J Radiat Oncol Biol Phys. 33:233–234.
32. Moran MS., 2015. Radiation therapy in the locoregional treatment of triple-negative breast cancer. Lancet Oncol. 16:e113–e122.
33. Mukherjee D, Coates PJ, Lorimore S, Wright EG., 2014. Responses to ionizing radiation mediated by inflammatory mechanisms. J Pathol. 232:289–299.
34. Nguyen DH, Oketch-Rabah H, Illa-Bochaca I, Geyer FC, Reis-Filho JS, Mao J-H, Ravani S, Zavadil J, Borowsky AD, Jerry DJ, et al. 2011. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell. 19:640–651.
35. Ohuchida K., 2004. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res. 64:3215–3222.
36. Palta M, Yoo S, Adamson JD, Prosnitz LR, Horton JK., 2012. Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol. 82:37–42.
37. Pantschenko AG, Pushkar I, Anderson KH, Wang Y, Miller LJ, Kurtzman SH, Barrows G, LDK., 2003. The interleukin-1 family of cytokines and receptors in human breast cancer:implications for tumor progression. Int J Oncol. 23:269–284.
38. Paquette B, Therriault H, Wagner JR., 2013. Role of interleukin-1β in radiation-enhancement of MDA-MB-231 breast cancer cell invasion. Radiat Res. 180:292–298.
39. Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, Park IC, Rhee CH, Hong SI., 2006. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res. 66:8511–8519.
40. Petrella BL, Armstrong DA, Vincenti MP., 2012. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells. Cancer Lett. 325:220–226.
41. Petrella BL, Vincenti MP., 2012. Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β. Cancer Med. 1:17–27.
42. Pham NA, Morrison A, Schwock J, Aviel-Ronen S, Iakovlev V, Tsao MS, Ho J, Hedley DW., 2007. Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol. 2:8.
43. Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, et al. 2010. Triple-negative breast cancer:present challenges and new perspectives. Mol Oncol. 4:209–229.
44. Qian L, Mizumoto K, Urashima T., 2002. Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res. 4:1223–1227.
45. Quarmby S, Kumar P, Kumar S., 1999. Radiation-induced normal tissue injury:role of adhesion molecules in leukocyte-endothelial cell interactions. Int J Cancer. 82:385–395.
46. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P., 2007. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells:differential regulation by inflammatory cytokines. Blood. 109:4055–4063.
47. Roland H, Veling SHJ, Mravunac M, Hendriks JHCL., 1985. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 56:979–990.
48. Schaue D, Kachikwu EL, McBride WH., 2012. Cytokines in radiobiological responses:a review. Radiat Res. 178:505–523.
49. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P, Meshel T, Shabtai E, Gutman M, et al. 2011. Inflammatory mediators in breast cancer:coordinated expression of TNFα and IL-1β with CCL2 and CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer. 11:130.
50. Speake WJ, Dean RA, Kumar A, Morris TM, Scholefield JH, Watson SA., 2005. Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion. Eur J Surg Oncol. 31:869–874.
51. St John MA., 2015. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma. Laryngoscope. 125(Suppl):S1–S11.
52. Sung W-W, Wang Y-C, Lin P-L, Cheng Y-W, Chen C-Y, Wu T-C, Lee H., 2013. IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma. Clin Cancer Res. 19:4092–4103.
53. Tortorelli G, Di Murro L, Barbarino R, Cicchetti S, di Cristino D, Falco MD, Fedele D, Ingrosso G, Janniello D, Morelli P, et al. 2013. Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer:a retrospective analysis of acute skin toxicity and dose inhomogeneities. BMC Cancer. 13:230.
54. Vidal-Vanaclocha F, Alvarez A, Asumendi A, Urcelay B, Tonino P, Dinarello CA., 1996. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst. 88:198–205.
55. Vidal-vanaclocha F, Amézaga C, Asumendi A, Kaplanski G., 1994. Interleukin-1 receptor blockade reduces the number and size of murine b16 melanoma hepatic metastases. Cancer Res. 54:2667–2672.
56. Vilalta M, Rafat M, Graves EE., 2016. Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci. 73:2999–3007.
57. von Essen CF., 1991. Radiation enhancement of metastasis:a review. Clin Exp Metastasis. 9:77–104.
58. Wang J, Shi M, Ling R, Xia Y, Luo S, Fu X, Xiao F, Li J, Long X, Hou Z, et al. 2011. Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma:a prospective randomized controlled multi-center trial. Radiother Oncol. 100:200–204.
59. Wang JL, Sun Y, Wu S., 2000. Gamma-irradiation induces matrix metalloproteinase II expression in a p53-dependent manner. Mol Carcinog. 27:252–258.
60. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, Robert NJ., 1992. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 10:356–363.
61. Wild-bode C, Weller M, Rimner A, Dichgans J, Wick W., 2001. Sublethal irradiation promotes migration and invasiveness of glioma cells:implications for radiotherapy of human glioblastoma. Cancer Res. 61:2744–2750.
62. Yano S, Nokihara H, Yamamoto A, Goto H, Ogawa H, Kanematsu T, Miki T, Uehara H, Saijo Y, Nukiwa T, et al. 2003. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci. 94:244–252.